Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Return on Assets (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Return on Assets for 15 consecutive years, with 0.0% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets rose 21.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 21.0% increase, with the full-year FY2025 number at 0.0%, up 20.0% from a year prior.
  • Return on Assets was 0.0% for Q4 2025 at Anika Therapeutics, up from 0.1% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.03% in Q2 2024 to a low of 0.25% in Q2 2025.
  • A 5-year average of 0.06% and a median of 0.03% in 2022 define the central range for Return on Assets.
  • Biggest YoY gain for Return on Assets was 21bps in 2025; the steepest drop was -29bps in 2025.
  • Anika Therapeutics' Return on Assets stood at 0.01% in 2021, then plummeted by -194bps to 0.01% in 2022, then dropped by -27bps to 0.01% in 2023, then plummeted by -1458bps to 0.22% in 2024, then skyrocketed by 98bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for ANIK's Return on Assets are 0.0% (Q4 2025), 0.1% (Q3 2025), and 0.25% (Q2 2025).